Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Klockgether

Showing results (61-70 of 332) with videos related to

Pageof 34
Sort By:
Frontiers in Neurology|July 5, 2022
Early Intracranial Hemorrhage Predicts Poor Clinical Outcome in Community-Acquired Bacterial MeningitisJohannes Weller, Jonas Simon Enkirch, Felix Lehmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 23, 2007
Bright light therapy in Parkinson's disease: a pilot studySebastian Paus, Tanja Schmitz-Hübsch, Ullrich Wüllner, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 21, 2020
Multiple system atrophy mimicry in MRI: Watch out for paraneoplastic rhombencephalitisElena Schlapakow, Vera C Keil, Marie Paus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 9, 2003
State of the art review: molecular diagnosis of inherited movement disorders. Movement Disorders Society task force on molecular diagnosisThomas Gasser, Susan Bressman, Alexandra Dürr, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 15, 2003
IFN-beta1a (Rebif) modifies the expression of microfilament-associated cell-cell contacts in C6 glioma cellsMichael Harzheim, Manuela Altenschmidt, Michael T Heneka, et al.
Neuroscience Letters|May 17, 2005
The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicityCarmen Noelker, Michael Bacher, Petra Gocke, et al.
Annals of Clinical and Translational Neurology|February 21, 2022
Evolution of disability in spinocerebellar ataxias type 1, 2, 3, and 6Heike Jacobi, Tamara Schaprian, Jan Beyersmann, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 5, 2002
Circulating adhesion molecules in patients with internal carotid artery stenosisThorsten Okulla, Sabine Gass, Katja Böhme, et al.
Journal of Neurology|August 18, 2004
Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2Cornelia Kornblum, Jürgen Reul, Wolfram Kress, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 12, 2022
The Ratio of Expanded to Normal Ataxin 3 in Peripheral Blood Mononuclear Cells Correlates with the Age at Onset in Spinocerebellar Ataxia Type 3Peter Breuer, Tim Rasche, Xinyu Han, et al.
Pageof 34

Showing results (61-70 of 332) with videos related to

Sort By:
Pageof 34
Frontiers in Neurology|July 5, 2022
Early Intracranial Hemorrhage Predicts Poor Clinical Outcome in Community-Acquired Bacterial MeningitisJohannes Weller, Jonas Simon Enkirch, Felix Lehmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 23, 2007
Bright light therapy in Parkinson's disease: a pilot studySebastian Paus, Tanja Schmitz-Hübsch, Ullrich Wüllner, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 21, 2020
Multiple system atrophy mimicry in MRI: Watch out for paraneoplastic rhombencephalitisElena Schlapakow, Vera C Keil, Marie Paus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 9, 2003
State of the art review: molecular diagnosis of inherited movement disorders. Movement Disorders Society task force on molecular diagnosisThomas Gasser, Susan Bressman, Alexandra Dürr, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 15, 2003
IFN-beta1a (Rebif) modifies the expression of microfilament-associated cell-cell contacts in C6 glioma cellsMichael Harzheim, Manuela Altenschmidt, Michael T Heneka, et al.
Neuroscience Letters|May 17, 2005
The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicityCarmen Noelker, Michael Bacher, Petra Gocke, et al.
Annals of Clinical and Translational Neurology|February 21, 2022
Evolution of disability in spinocerebellar ataxias type 1, 2, 3, and 6Heike Jacobi, Tamara Schaprian, Jan Beyersmann, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 5, 2002
Circulating adhesion molecules in patients with internal carotid artery stenosisThorsten Okulla, Sabine Gass, Katja Böhme, et al.
Journal of Neurology|August 18, 2004
Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2Cornelia Kornblum, Jürgen Reul, Wolfram Kress, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 12, 2022
The Ratio of Expanded to Normal Ataxin 3 in Peripheral Blood Mononuclear Cells Correlates with the Age at Onset in Spinocerebellar Ataxia Type 3Peter Breuer, Tim Rasche, Xinyu Han, et al.
Pageof 34